Lobular carcinoma in situ

HY Wen, E Brogi - Surgical pathology clinics, 2018 - Elsevier
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 …

TM Elsheikh, JF Silverman - The American journal of surgical …, 2005 - journals.lww.com
Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) diagnosed in core
needle biopsy (CNB) are generally regarded as risk indicators for developing invasive …

Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision

MP Murray, C Luedtke, L Liberman, T Nehhozina… - Cancer, 2013 - Wiley Online Library
BACKGROUND: No consensus exists on the need to excise breast lesions that yield classic
lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)(known together as …

Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy

MH Rendi, SM Dintzis, CD Lehman… - Annals of surgical …, 2012 - Springer
Background The surgical management of lobular in-situ neoplasia (LN) identified by core
needle biopsy (CNB) is currently variable. Our institution has routinely excised LN on CNB …

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve‐year observations concerning lobular carcinoma in situ

ER Fisher, SR Land, B Fisher, E Mamounas… - Cancer, 2004 - Wiley Online Library
BACKGROUND The current report represents a 12‐year clinicopathologic update of an
earlier 5‐year analysis of 180 patients with lobular carcinoma in situ (LCIS) who were …

Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?

MC Foster, MA Helvie, NE Gregory, M Rebner… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To retrospectively determine frequency of invasive cancer or ductal carcinoma in
situ (DCIS) at excisional biopsy in women with atypical lobular hyperplasia (ALH) or lobular …

Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast–a review

M Hussain, GH Cunnick - European Journal of Surgical Oncology, 2011 - Elsevier
OBJECTIVES: To determine the incidence of malignancy (invasive carcinoma or DCIS) in
patients diagnosed with lobular neoplasia (B3) on core needle biopsy (CNB) of breast …

[HTML][HTML] Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review

KL Mooney, LW Bassett, SK Apple - Modern Pathology, 2016 - Elsevier
Optimal management of high-risk breast lesions detected by mammogram yielding atypical
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in …

Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective …

F Nakhlis, L Gilmore, R Gelman, I Bedrosian… - Annals of surgical …, 2016 - Springer
Background Lobular neoplasia (LN) represents a spectrum of atypical proliferative lesions,
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …

Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy

MG Shah-Khan, XJ Geiger, C Reynolds… - Annals of surgical …, 2012 - Springer
Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …